Results 21 to 30 of about 1,572 (180)
AbstractObjectiveNeurodegeneration with brain iron accumulation (NBIA) is a group of disorders characterized by magnetic resonance imaging (MRI) changes in basal ganglia. Both missense and nonsense mutations have been found in such patients in a gene encoding the mitochondrial pantothenate kinase (PANK2).MethodsWe completed a mutation screen in 72 ...
Hartig, Monika B. +15 more
core +5 more sources
A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study [PDF]
Background Neurodegeneration with brain iron accumulation (NBIA) is a group of genetic neurological disorders frequently associated with iron accumulation in the basal nuclei of the brain characterized by progressive spasticity, dystonia, muscle rigidity,
Alessandra Pereira +4 more
doaj +2 more sources
GPi-DBS for SERAC1-Related Dystonia-Parkinsonism. [PDF]
Movement Disorders Clinical Practice, Volume 13, Issue 2, Page 568-571, February 2026.
Yahya V +13 more
europepmc +2 more sources
Pantothenate kinase-associated neurodegeneration is a rare hereditary neurodegenerative disorder associated with nucleotide variation(s) in mitochondrial human Pantothenate kinase 2 (hPanK2) protein encoding PANK2 gene, and is characterized by symptoms ...
Arshia Angural +10 more
doaj +2 more sources
iPSC-derived neuronal models of PANK2-associated neurodegeneration reveal mitochondrial dysfunction contributing to early disease. [PDF]
Mutations in PANK2 lead to neurodegeneration with brain iron accumulation. PANK2 has a role in the biosynthesis of coenzyme A (CoA) from dietary vitamin B5, but the neuropathological mechanism and reasons for iron accumulation remain unknown.
Charles Arber +13 more
doaj +2 more sources
PKAN is an autosomal recessive disorder with mutations in the PANK2 gene, encoding an essen- tial enzyme for CoA biosynthesis. The molecular connection between defects in this enzyme and the neurodegenerative phenotype observed in PKAN patients is still poorly understood.
Khatri, D. +5 more
openaire +2 more sources
Coenzyme A corrects pathological defects in human neurons of PANK2‐associated neurodegeneration
Pantothenate kinase‐associated neurodegeneration (PKAN) is an early onset and severely disabling neurodegenerative disease for which no therapy is available.
Daniel I Orellana +15 more
doaj +2 more sources
Pantothenate Kinase-associated Neurodegeneration (PKAN) is an autosomal recessive disorder that is caused by variation in pantothenate kinase-2 gene (PANK2) gene on chromosome 20.
Amir Hasan Habibi +7 more
doaj +3 more sources
Dyslipidemia and hypercalciuria in a patient with pantothenate kinase 2 deficiency: A novel variant and case report [PDF]
Pantothenate kinase-associated neurodegeneration (PKAN, OMIM: 234200) results from biallelic pathogenic variants in PANK2 which encodes pantothenate kinase 2, a crucial mitochondrial enzyme involved in coenzyme A biosynthesis.
Henry-Marcelo Rodriguez-Perez +5 more
doaj +2 more sources
The down-regulation of pank2 gene in zebrafish as a model of Pantothenate Kinase Associated Neurodegeneration. [PDF]
The increased iron deposition is a hallmark of many neurodegenerative diseases, but its pathogenic role is still unclear. A strong link between iron and neurodegeneration is evident in a set of heterogeneous neurological disorders, known as Neurodegeneration with Brain Iron Accumulation (NBIA).
TISO, NATASCIA +8 more
openaire +3 more sources

